Publications by authors named "Gary Jennings"

Claim this Profile
A
Alzheimer's Disease: A Brief History of Immunotherapies Targeting Amyloid β.
Anne-Cathrine S Vogt, Gary T Jennings, Mona O Mohsen, Monique Vogel, Martin F Bachmann

Int J Mol Sci· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A scalable and highly immunogenic virus-like particle-based vaccine against SARS-CoV-2.
Mona O Mohsen, Ina Balke, Simon Zinkhan, Villija Zeltina, Xuelan Liu, Gary T Jennings

Allergy· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Structural binding site comparisons reveal Crizotinib as a novel LRRK2 inhibitor.
Sarah Naomi Bolz, Sebastian Salentin, Gary Jennings, V Joachim Haupt, Jared Sterneckert

Comput Struct Biotechnol J· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Structure-based drug repositioning explains ibrutinib as VEGFR2 inhibitor.
Melissa F Adasme, Daniele Parisi, Kristien Van Belle, Sebastian Salentin, V Joachim Haupt, Gary S Jennings

PLoS One· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunization of Cats against Fel d 1 Results in Reduced Allergic Symptoms of Owners.
Franziska Thoms, Stefanie Haas, Aline Erhart, Claudia S Nett, Silvia Rüfenacht, Gary T Jennings

Viruses· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lipidomimetic Compounds Act as HIV-1 Entry Inhibitors by Altering Viral Membrane Structure.
Jon Ander Nieto-Garai, Bärbel Glass, Carmen Bunn, Matthias Giese, Gary Jennings

Front Immunol· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Miltefosine treatment reduces visceral hypersensitivity in a rat model for irritable bowel syndrome via multiple mechanisms.
Sara Botschuijver, Sophie A van Diest, Isabelle A M van Thiel, Rafael S Saia, Anne S Strik, Gary Jennings

Sci Rep· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunization of cats to induce neutralizing antibodies against Fel d 1, the major feline allergen in human subjects.
Franziska Thoms, Gary T Jennings, Melanie Maudrich, Monique Vogel, Stefanie Haas

J Allergy Clin Immunol· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A vaccine against Alzheimer`s disease: anything left but faith?
Martin F Bachmann, Gary T Jennings, Monique Vogel

Expert Opin Biol Ther· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incorporation of tetanus-epitope into virus-like particles achieves vaccine responses even in older recipients in models of psoriasis, Alzheimer's and cat allergy.
Andris Zeltins, Jonathan West, Franziska Zabel, Aadil El Turabi, Ina Balke, Gary T Jennings

NPJ Vaccines· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of an Interleukin-1β Vaccine in Patients with Type 2 Diabetes.
Claudia Cavelti-Weder, Katharina Timper, Eleonora Seelig, Cornelia Keller, Martin Osranek, Gary T Jennings

Mol Ther· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Particle-based platforms for malaria vaccines.
Yimin Wu, David L Narum, Sylvain Fleury, Gary Jennings, Anjali Yadava

Vaccine· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preclinical efficacy and safety of an anti-IL-1β vaccine for the treatment of type 2 diabetes.
Gunther Spohn, Christian Schori, Iris Keller, Katja Sladko, Christina Sina, Gary T Jennings

Mol Ther Methods Clin Dev· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bacterially produced recombinant influenza vaccines based on virus-like particles.
Andrea Jegerlehner, Franziska Zabel, Alice Langer, Klaus Dietmeier, Gary T Jennings

PLoS One· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of steroidal amines as lipid raft modulators and potential anti-influenza agents.
Sameer Agarwal, Cornelia Schroeder, Georg Schlechtingen, Tobias Braxmeier, Gary Jennings

Bioorg Med Chem Lett· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A VLP-based vaccine against interleukin-1α protects mice from atherosclerosis.
Alain C Tissot, Gunther Spohn, Gary T Jennings, Abdijapar Shamshiev, Michael O Kurrer

Eur J Immunol· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapeutic vaccines for chronic diseases: successes and technical challenges.
Martin F Bachmann, Gary T Jennings

Philos Trans R Soc Lond B Biol Sci· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The second-generation active Aβ immunotherapy CAD106 reduces amyloid accumulation in APP transgenic mice while minimizing potential side effects.
Christoph Wiessner, Karl-Heinz Wiederhold, Alain C Tissot, Peter Frey, Simone Danner, Gary T Jennings

J Neurosci· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A virus-like particle-based anti-nerve growth factor vaccine reduces inflammatory hyperalgesia: potential long-term therapy for chronic pain.
Till A Röhn, William T Ralvenius, Jolly Paul, Petra Borter, Marcela Hernandez, Gary T Jennings

J Immunol· February 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Structural design, solid-phase synthesis and activity of membrane-anchored β-secretase inhibitors on Aβ generation from wild-type and Swedish-mutant APP.
Heinke Schieb, Sebastian Weidlich, Georg Schlechtingen, Philipp Linning, Gary Jennings

Chemistry· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vaccine delivery: a matter of size, geometry, kinetics and molecular patterns.
Martin F Bachmann, Gary T Jennings

Nat Rev Immunol· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A VLP-based vaccine targeting domain III of the West Nile virus E protein protects from lethal infection in mice.
Gunther Spohn, Gary T Jennings, Byron Ee Martina, Iris Keller, Markus Beck

Virol J· July 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Computational screening for membrane-directed inhibitors of mast cell activation.
José Batista, Tim Friedrichson, Georg Schlechtingen, Tobias Braxmeier, Gary Jennings

Eur J Med Chem· June 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combined vaccination against IL-5 and eotaxin blocks eosinophilia in mice.
Yu Zou, Ivo Sonderegger, Gerd Lipowsky, Gary T Jennings, Nicole Schmitz

Vaccine· April 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Versatile virus-like particle carrier for epitope based vaccines.
Alain C Tissot, Regina Renhofa, Nicole Schmitz, Indulis Cielens, Edwin Meijerink, Gary T Jennings

PLoS One· March 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis